Our team aims to make discoveries in the field of Alzheimer鈥檚 and neurodegenerative disease, using applied research that spans across community settings to aged care, employing co-design and implementation science frameworks to deliver maximal discovery and translation opportunities for future care.
Alzheimer鈥檚 is the most common cause of dementia and is a neurodegenerative disease. Dementia is the second leading cause of death for all Australians.
Initially, the team will focus on discovery of how changes in blood can yield new mechanistic insights into cognitive decline and neuroimaging biomarkers, and how these may change in response to major stressors (e.g. surgery), modifiable dementia risk factors (alcohol, blood pressure, sleep, depression), and in novel therapies targeting amyloid, tau or neuroinflammation. The team will conduct innovative work within clinical cohorts derived from the Brain and Mind Centre鈥檚 Healthy Brain Ageing Program, as well as from large existing databanks such as the UK biobank.
We work to assess, prevent and treat cognitive decline, dementia, Alzheimer鈥檚 disease and depression in older adults.
Professor
Associate Professor
Professor
Associate Professor
Professor
Dr
Associate Professor
Dr
Dr Hannes Almgren
Dr Zac Chatterton
Dr Tomas Kavanagh
Dr
Dr Emma Devenney
Dr Tomas Kavanagh
Dr
Dr
Dr Shawn Kong
Dr
Dr Zoe Schrire
Dr
Dr Hannes Almgren
Dr
Dr Jennifer Taylor
Dr Ka Ka Ting
Dr Zac Chatterton
Dr
Dr Nathan Cross
Mr Hamish Mundell
Professor
Professor
Phone: +61 2 9351 0774
Email: brainandmind.info@sydney.edu.au
94 Mallett Street, Camperdown NSW 2050
Opening hours: Monday to Friday, 9am to 5pm
